DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Abelcet (Amphotericin B) - Blood Bilirubin Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Blood Bilirubin Increased (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Abelcet (Amphotericin B) where reactions include blood bilirubin increased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Abelcet side effects in 56 year old male

Reported by a physician from United States on 2011-12-27

Patient: 56 year old male

Reactions: Multi-Organ Failure, Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Renal Failure, Aspartate Aminotransferase Increased, Acute Respiratory Distress Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Abelcet



Possible Abelcet side effects in 74 year old female

Reported by a individual with unspecified qualification from United States on 2011-12-27

Patient: 74 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Blood Bilirubin Increased, Renal Impairment, Laboratory Test Interference, Blood Creatinine Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Abelcet
    Dosage: 335 mg, qd, iv
    Indication: Systemic Mycosis
    Start date: 1996-12-03
    End date: 1996-12-10

Amphotericin B
    Dosage: 40 mg, qd, iv
    Indication: Systemic Mycosis
    Start date: 1996-11-28
    End date: 1996-12-01

Other drugs received by patient: Gentamicin; Vancomycin; Cytarabine; Mitoxantrone; Etoposide; Ciprofloxacin; Immunoglobulin Human Normal; Aztreonam



Possible Abelcet side effects in female

Reported by a physician from United States on 2011-11-15

Patient: female, weighing 57.5 kg (126.5 pounds)

Reactions: Blood Bilirubin Increased, Chest Discomfort, Dyspnoea, Wheezing, Blood Albumin Decreased, Drug Interaction, Pyrexia, Renal Impairment, Oedema Peripheral, Hypoxia, Aspergillosis, Pulmonary Oedema, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abelcet

Gleevec
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2004-03-14
    End date: 2004-03-23

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient possibly interacting with the suspect drug:
Voriconazole

Other drugs received by patient: Hydrea; Acyclovir; Vancomycin; Oxycodone HCL; Zosyn; Gentamicin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017